(Z)-isoquinolin-5(4aH)-one oxiMe
|
- $414 - $1429
- Product name: (Z)-isoquinolin-5(4aH)-one oxiMe
- CAS: 1492042-51-9
- MF: C9H8N2O
- MW: 160.17
- EINECS:
- MDL Number:MFCD27991318
- Synonyms:5-nitroso-2,4a-dihydroisoquinoline;(Z)-isoquinolin-5(4aH)-one oxiMe;5-Isoquinolinamine, N-hydroxy-
5 prices
Selected condition：
Brand
- Alichem
- Chemenu
- Crysdot
Package
- 250mg
- 1g
- 5g
- ManufacturerAlichem
- Product number1492042519
- Product descriptionIsoquinolin-5(4aH)-oneoxime
- Packaging250mg
- Price$414
- Updated2021-12-16
- Buy
- ManufacturerAlichem
- Product number1492042519
- Product descriptionIsoquinolin-5(4aH)-oneoxime
- Packaging1g
- Price$1107.45
- Updated2021-12-16
- Buy
- ManufacturerChemenu
- Product numberCM223430
- Product descriptionIsoquinolin-5(4aH)-oneoxime 95%
- Packaging1g
- Price$968
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11372459
- Product description(Z)-Isoquinolin-5(4aH)-oneoxime 95+%
- Packaging5g
- Price$1429
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11372459
- Product description(Z)-Isoquinolin-5(4aH)-oneoxime 95+%
- Packaging1g
- Price$475
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| Alichem | 1492042519 | Isoquinolin-5(4aH)-oneoxime | 250mg | $414 | 2021-12-16 | Buy |
| Alichem | 1492042519 | Isoquinolin-5(4aH)-oneoxime | 1g | $1107.45 | 2021-12-16 | Buy |
| Chemenu | CM223430 | Isoquinolin-5(4aH)-oneoxime 95% | 1g | $968 | 2021-12-16 | Buy |
| Crysdot | CD11372459 | (Z)-Isoquinolin-5(4aH)-oneoxime 95+% | 5g | $1429 | 2021-12-16 | Buy |
| Crysdot | CD11372459 | (Z)-Isoquinolin-5(4aH)-oneoxime 95+% | 1g | $475 | 2021-12-16 | Buy |
Properties
Boiling point :376.6±34.0 °C(Predicted)
Density :1.366±0.06 g/cm3(Predicted)
pka :8.58±0.30(Predicted)
Density :1.366±0.06 g/cm3(Predicted)
pka :8.58±0.30(Predicted)
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|